Mark Britton

604 total citations
18 papers, 455 citations indexed

About

Mark Britton is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark Britton has authored 18 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark Britton's work include Occupational and environmental lung diseases (6 papers), Asthma and respiratory diseases (5 papers) and Sarcoma Diagnosis and Treatment (2 papers). Mark Britton is often cited by papers focused on Occupational and environmental lung diseases (6 papers), Asthma and respiratory diseases (5 papers) and Sarcoma Diagnosis and Treatment (2 papers). Mark Britton collaborates with scholars based in United Kingdom, United States and Canada. Mark Britton's co-authors include R. Lambert, J.V. Collins, D Brown, David T. Hughes, J.A. Forrester, R.J. Davies, Tania J. Phillips, Eric Seal, Harry Rutter and M. Horrigan and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Mark Britton

17 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Britton United Kingdom 8 374 98 57 40 36 18 455
CL Hart United Kingdom 5 162 0.4× 83 0.8× 39 0.7× 24 0.6× 14 0.4× 7 343
Charlotte Colp United States 13 243 0.6× 162 1.7× 23 0.4× 62 1.6× 24 0.7× 24 407
Lawrence G. McAlpine United Kingdom 13 289 0.8× 119 1.2× 47 0.8× 20 0.5× 6 0.2× 19 452
Ellen Bloom Marcus United States 11 264 0.7× 116 1.2× 40 0.7× 35 0.9× 5 0.1× 14 461
A. Sonia Buist United States 7 203 0.5× 170 1.7× 25 0.4× 20 0.5× 16 0.4× 9 446
Nicola Sinden United Kingdom 8 294 0.8× 106 1.1× 21 0.4× 47 1.2× 51 1.4× 9 569
Michael T. Zvarich United Kingdom 5 565 1.5× 274 2.8× 40 0.7× 66 1.6× 20 0.6× 8 634
María-Teresa García-Sanz Spain 12 254 0.7× 127 1.3× 15 0.3× 25 0.6× 19 0.5× 20 316
Robert S. Crausman United States 11 196 0.5× 149 1.5× 38 0.7× 24 0.6× 8 0.2× 30 393
Thomas J. Bassler United States 10 178 0.5× 35 0.4× 46 0.8× 24 0.6× 22 0.6× 32 433

Countries citing papers authored by Mark Britton

Since Specialization
Citations

This map shows the geographic impact of Mark Britton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Britton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Britton more than expected).

Fields of papers citing papers by Mark Britton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Britton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Britton. The network helps show where Mark Britton may publish in the future.

Co-authorship network of co-authors of Mark Britton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Britton. A scholar is included among the top collaborators of Mark Britton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Britton. Mark Britton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ryan, Dermot, Feargal J. Ryan, Dinesh Saralaya, et al.. (2012). P276 The Impact of the Optimum Patient Care Service on Outcomes for Adult Asthmatic Patients: Abstract P276 Table 1. Thorax. 67(Suppl 2). A186.1–A186.
2.
Britton, Mark, Timothy R. Howes, Dinesh Saralaya, et al.. (2011). Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 3 UK centres. European Respiratory Journal. 38(Suppl 55). p273–p273. 2 indexed citations
3.
Britton, Mark. (2003). The burden of COPD in the U.K.: results from the confronting COPD survey. Respiratory Medicine. 97. S71–S79. 160 indexed citations
4.
Higgins, Bernard, et al.. (2003). Anti-IgE therapy with omalizumab improves asthma-related quality of life of patients with poorly controlled allergic asthma. Journal of Allergy and Clinical Immunology. 111(2). S144–S144. 4 indexed citations
5.
Britton, Mark. (2002). The epidemiology of mesothelioma. Seminars in Oncology. 29(1). 18–25. 132 indexed citations
6.
Britton, Mark, et al.. (1998). Screening, Diagnostic and Outcome Tools for Asthma. Disease Management & Health Outcomes. 3(5). 229–238. 1 indexed citations
7.
Seal, Eric, Harry Rutter, M. Horrigan, & Mark Britton. (1997). Left atrial tumour mimicking pulmonary embolism. Respiratory Medicine. 91(9). 562–564. 7 indexed citations
8.
Britton, Mark, et al.. (1991). Pulmonary artery leiomyosarcoma. Respiratory Medicine. 85(4). 337–338. 2 indexed citations
9.
Britton, Mark, et al.. (1989). The value of ear lobe oximetry in the assessment of disability in asbestos-related disease. Respiratory Medicine. 83(1). 43–49. 5 indexed citations
10.
Britton, Mark. (1989). Compensation for asbestos-related diseases—the U.K. model. Respiratory Medicine. 83(2). 95–102. 7 indexed citations
11.
Britton, Mark, et al.. (1983). Asthma in merchant seamen and laboratory workers caused by allergy to castor beans: analysis of allergens. Clinical & Experimental Allergy. 13(6). 553–561. 19 indexed citations
12.
Britton, Mark. (1982). Asbestos pleural disease. British Journal of Diseases of the Chest. 76(1). 1–10. 31 indexed citations
13.
Britton, Mark, et al.. (1981). A guide to compensation for asbestos-related diseases.. BMJ. 282(6282). 2107–2111. 10 indexed citations
14.
Britton, Mark, et al.. (1977). Serial pulmonary function tests in patients with asbestosis.. Thorax. 32(1). 45–52. 7 indexed citations
15.
Britton, Mark, et al.. (1976). High-dose corticosteroids in severe acute asthma.. BMJ. 2(6027). 73–74. 56 indexed citations
16.
Britton, Mark, et al.. (1976). Evaluation of Two Spirometers. CHEST Journal. 70(2). 244–250. 6 indexed citations
17.
Britton, Mark, et al.. (1976). A Survey of Patients Diagnosed as Having Asbestosis. Medicine Science and the Law. 16(4). 279–284. 1 indexed citations
18.
Collins, J.V., et al.. (1975). Hypothalamo-pituitary-adrenal function in intrinsic non-atopic asthma.. Thorax. 30(5). 578–581. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026